by Karen Weintraub | Dec 18, 2023 | Blog
Nuedexta, a drug marketed for Pseudobulbar Affect (PBA), a condition causing uncontrollable laughing or crying, finds itself under a cloud of controversy. According to the manufacturer[1]: “PBA is a medical condition that causes involuntary, sudden, and frequent...
by Shannon Sifrig | Nov 21, 2023 | Blog
In this article, we discuss Adderall and its treatment for Attention-Deficit/Hyperactivity Disorder (ADHD) as well concerns expressed by Federal agencies regarding Adderall drug shortages including a range of factors leading to such shortages such as off-label...
by Karen Weintraub | Oct 31, 2023 | Blog
Who has enough time in their day to do everything you need to do? Almost no one. If you are going to the NHCAA Annual Training Conference in Dallas, then you don’t want to miss this session. If you aren’t able to attend, let us know and we can provide you...
by Karen Weintraub | Sep 19, 2023 | Blog
There has been a seismic change to the coding and reimbursement for sacroiliac (SI) joint procedures over the last few years – we’re “transfixed” on this hot topic. New and disruptive minimally invasive procedures and techniques have come onto the market since 2018-...
by Karen Weintraub | Aug 22, 2023 | Blog
For those afflicted with diabetes, managing all the different devices and the disease may feel like a daunting task. Even more intimidating may be learning what devices are covered and how much is covered. There are many different ways to treat and monitor diabetes....